 ElectroCore Inc NASDAQ: ECOR has announced top-line results from the SAVIOR-1 study evaluating non-invasive vagus nerve stimulation nVNS using gammaCore Sapphire in hospitalized COVID-19 patients. The investigator-initiated trial conducted in Spain was designed to evaluate the safety and feasibility of nVNS in addition to the current standard of care. 